Skip to content
Search

Latest Stories

Top Stories

Cuts to science research funding cut American lives short − federal support is essential for medical breakthroughs

Cuts to science research funding cut American lives short − federal support is essential for medical breakthroughs

A stethoscope and medical charts.

Getty Images, krisanapong detraphiphat

Nearly every modern medical treatment can be traced to research funded by the National Institutes of Health: from over-the-counter and prescription medications that treat high cholesterol and pain to protection from infectious diseases such as polio and smallpox.

The remarkable successes of the decades-old partnership between biomedical research institutions and the federal government are so intertwined with daily life that it’s easy to take them for granted.


However, the scientific work driving these medical advances and breakthroughs is in jeopardy. Federal agencies such as the National Institutes of Health and the National Science Foundation are terminating hundreds of active research grants under the current administration’s direction. The administration has also proposed a dramatic reduction in federal support of the critical infrastructure that keeps labs open and running. Numerous scientists and health professionals have noted that changes will have far-reaching, harmful outcomes for the health and well-being of the American people.

The negative consequences of defunding U.S. biomedical research can be difficult to recognize. Most breakthroughs, from the basic science discoveries that reveal the causes of diseases to the development of effective treatments and cures, can take years. Real-time progress can be hard to measure.

Medical breakthroughs are built on years of painstaking research. Scott Olson/Getty Image

As biomedical researchers studying infectious diseases, viruses and immunology, we and our colleagues see this firsthand in our own work. Thousands of ongoing national and international projects dedicated to uncovering the causes of life-threatening diseases and developing new treatments to improve and save lives are supported by federal agencies such as the NIH and NSF.

Considering a few of the breakthroughs made possible through U.S. federal support can help illustrate not only the significant inroads biomedical research has made for preventing, treating and curing human maladies, but what all Americans stand to lose if the U.S. reduces its investment in these endeavors.

A cure for cancer

The hope and dream of curing cancer unites many scientists, health professionals and affected families across the U.S. After decades of ongoing NIH-supported research, scientists have made significant progress in realizing this goal.

The National Cancer Institute of the NIH is the world’s largest funder of cancer research. This investment has led to advances in cancer treatment and prevention that helped reduce the overall U.S. cancer death rate by 33% from 1991 to 2021.

Basic science research on what causes cancer has led to new strategies to harness a patient’s own immune system to eliminate tumors. For example, all 12 patients in a 2022 clinical trial testing one type of immunotherapy had their rectal cancer completely disappear, without remission or adverse effects.

- YouTubeyoutu.be

Another example of progress is the 2024 results of an ongoing clinical trial of a targeted therapy for lung cancer, showing an 84% reduction in the risk of disease progression or death. Similarly, in a study of women who were immunized against the human papillomavirus at age 12 or 13, none developed the disease later. Since the widespread adoption of HPV vaccination, cervical cancer deaths have dropped 62%.

Despite these incredible successes, there is still a long way to go. In 2024, over 2 million people in the U.S. were estimated to be newly diagnosed with cancer, and 611,720 were expected to die from the disease.

Without sustained federal support for cancer research, progress toward curing cancer and reducing its death rate will stall.

Autoimmune and neurodegenerative diseases

Nearly every family is touched in some way by autoimmune and neurodegenerative diseases. Government-funded research has enabled major advances to combat conditions such as rheumatoid arthritis, multiple sclerosis, Parkinson’s and Alzheimer’s disease.

For example, approximately 1 in 5 Americans have arthritis, an autoimmune disease that causes joint swelling and stiffness. A leading cause of disability and economic costs in the U.S., there is no cure for arthritis. But new drugs in development are able to significantly improve symptoms and slow or prevent disease progression.

Researchers are also gaining insight into what causes multiple sclerosis, an autoimmune disease where the immune system attacks the protective covering of nerves and can result in paralysis. Scientists recently found a link between multiple sclerosis and Epstein-Barr virus, a pathogen estimated to infect over 90% of adults around the world. While multiple sclerosis is currently incurable, identifying its underlying cause can provide new avenues for prevention and treatment.

The NIH’s BRAIN Initiative has invested more than $3 billion in neuroscience research since it began in 2013. Mandel Ngan/AFP via Getty Images

Alzheimer’s disease causes irreversible nerve damage and is the leading cause of dementia. In 2024, 6.9 million Americans ages 65 and older were living with Alzheimer’s. Most treatments address cognitive and behavioral symptoms. However, two new drugs developed with NIH-supported research and clinical trials were approved in July 2023 and July 2024 to treat early-stage Alzheimer’s. Federal funding is also supporting the development of blood tests for earlier detection of the disease.

None of these breakthroughs are a cure. But they represent important steps forward on the path toward ultimately reducing or eliminating these devastating ailments. Lack of funding will slow or block further progress, leading to the continued rise of the incidence and severity of these conditions.

Infectious diseases and the next pandemic

The world’s capacity to combat infectious disease will also be weakened by cuts to U.S. federal support of biomedical research.

Over the past 50 years, medical and public health advances have led to the eradication of smallpox globally and the elimination of polio in the U.S. HIV/AIDS, once a death sentence, is now a disease that can be managed with medication. Moreover, a new version of treatments called preexposure prophylaxis, or PrEP, offers complete protection against HIV transmission when taken only twice per year.

Similarly, the COVID-19 pandemic highlights the critical role biomedical research plays in responding to public health threats. Increased federal support of science during this time allowed the United States to emerge with new drugs, vaccine platforms with the potential to treat a variety of chronic diseases, and insights on how to effectively detect and respond to pandemic threats.

The ongoing avian influenza outbreak and its spillover into American dairy herds and poultry farms is another pandemic threat looming on the horizon. Rather than build upon infrastructure for outbreak surveillance and preparedness, grants that would allow scientists to better understand long COVID-19, vaccines and other pandemic-related research are being cut. Decreased funding of biomedical research will hamper the U.S.’s ability to respond to the next pandemic, putting everyone at risk.

Research across the country has ground to a halt as grants remain in limbo or have been terminated altogether. Scott Olson/Getty Images

Losses from defunding biomedical research

The National Institutes of Health contributed over $100 billion to support research that ultimately led to the development of all new drugs approved from 2010 to 2016 alone. Over 90% of this funding was for basic research into understanding the causes of disease that provides the foundation for new treatments.

Under the new directive to eliminate projects that support or use terms associated with diversity, equity and inclusion, the NIH and other federal agencies have made deep cuts to biomedical research that will directly affect patient lives.

Already, nearly 41% of Americans will be diagnosed with cancer at some point in their lifetime, and nearly 11% with Alzheimer’s. About 1 in 5 Americans will die from heart disease, and nearly 1.4 million will be rushed to an emergency room due to pneumonia from an infectious disease.

Defunding biomedical research will result in a cascade of effects. There will likely be fewer clinical trials, fewer new treatments and fewer lifesaving drugs. Labs will likely shut down, jobs will be lost, and the process of discovery will stall. The U.S.’s health care system, economy and standing as the world’s leader in scientific innovation will likely decline.

Moreover, when the pipelines of scientific progress are turned off, they will not so easily be turned back on. These consequences will affect all Americans and the rest of the world for decades.

University shortfalls directly resulting from cuts to research support will dramatically reduce the capacity of American institutions to educate and provide opportunities for the next generation. Funding cuts have led to the shuttering or heavy reduction of training programs for future scientists.

Graduate students and postdoctoral trainees are the lifeblood of biomedical research. Supporting these young people committed to public service through research and health care is also an investment in medical advancements and public health. But the uncertainty and instability resulting from the divestment of federally funded programs will likely severely deplete the biomedical workforce, crippling the United States’ ability to deliver future biomedical breakthroughs.

By cutting biomedical research funding, Americans and the rest of the world stand to lose new cures, new treatments and an entire generation of researchers.

Cuts to science research funding cut American lives short − federal support is essential for medical breakthroughs was originally published in The Conversation and shared with permission.

Deborah Fuller is a Professor of Microbiology at the School of Medicine of the University of Washington.

Patrick Mitchell is an Assistant Professor of Microbiology at the School of Medicine of the University of Washington.

Read More

Why Fed Independence Is a Cornerstone of Democracy—and Why It’s Under Threat
1 U.S.A dollar banknotes

Why Fed Independence Is a Cornerstone of Democracy—and Why It’s Under Threat

In an era of rising polarization and performative politics, few institutions remain as consequential and as poorly understood by citizens as the Federal Reserve.

While headlines swirl around inflation, interest rates, and stock market reactions, the deeper story is often missed: the Fed’s independence is not just a technical matter of monetary policy. It’s a democratic safeguard.

Keep ReadingShow less
An oil drilling platform with a fracking rig.

An oil drilling platform with a fracking rig extracts valuable resources from beneath the earth's surface.

Getty Images, grandriver

Trump Says America’s Oil Industry Is Cleaner Than Other Countries’. New Data Shows Massive Emissions From Texas Wells.

Hakim Dermish moved to the small South Texas town of Catarina in 2002 in search of a rural lifestyle on a budget. The property where he lived with his wife didn’t have electricity or sewer lines at first, but that didn’t bother him.

“Even if we lived in a cardboard box, no one could kick us out,” Dermish said.

Keep ReadingShow less
Following Jefferson: Promoting Inter-Generational Understanding Through Constitution-Making
Mount Rushmore
Photo by John Bakator on Unsplash

Following Jefferson: Promoting Inter-Generational Understanding Through Constitution-Making

No one can denounce the New York Yankee fan for boasting that her favorite ballclub has won more World Series championships than any other. At 27 titles, the Bronx Bombers claim more than twice their closest competitor.

No one can question admirers of the late, great Chick Corea, or the equally astonishing Alison Krauss, for their virtually unrivaled Grammy victories. At 27 gold statues, only Beyoncé and Quincy Jones have more in the popular categories.

Keep ReadingShow less
A close up of the Immigration and Customs Enforcement badge.

Trump’s mass deportations promise security but deliver economic pain, family separation, and chaos. Here’s why this policy is failing America.

Getty Images, Tennessee Witney

The Cruel Arithmetic of Trump’s Immigration Crackdown

As summer 2025 winds down, the Trump administration’s deportation machine is operating at full throttle—removing over one million people in six months and fulfilling a campaign promise to launch the “largest deportation operation in American history.” For supporters, this is a victory lap for law and order. For the rest of the lot, it’s a costly illusion—one that trades complexity for spectacle and security for chaos.

Let’s dispense with the fantasy first. The administration insists that mass deportations will save billions, reduce crime, and protect American jobs. But like most political magic tricks, the numbers vanish under scrutiny. The Economic Policy Institute warns that this policy could destroy millions of jobs—not just for immigrants but for U.S.-born workers in sectors like construction, elder care, and child care. That’s not just a fiscal cliff—it is fewer teachers, fewer caregivers, and fewer homes built. It is inflation with a human face. In fact, child care alone could shrink by over 15%, leaving working parents stranded and employers scrambling.

Meanwhile, the Peterson Institute projects a drop in GDP and employment, while the Penn Wharton School’s Budget Model estimates that deporting unauthorized workers over a decade would slash Social Security revenue and inflate deficits by nearly $900 billion. That’s not a typo. It’s a fiscal cliff dressed up as border security.

And then there’s food. Deporting farmworkers doesn’t just leave fields fallow—it drives up prices. Analysts predict a 10% spike in food costs, compounding inflation and squeezing families already living paycheck to paycheck. In California, where immigrant renters are disproportionately affected, eviction rates are climbing. The Urban Institute warns that deportations are deepening the housing crisis by gutting the construction workforce. So much for protecting American livelihoods.

But the real cost isn’t measured in dollars. It’s measured in broken families, empty classrooms, and quiet despair. The administration has deployed 10,000 armed service members to the border and ramped up “self-deportation” tactics—policies so harsh they force people to leave voluntarily. The result: Children skipping meals because their parents fear applying for food assistance; Cancer patients deported mid-treatment; and LGBTQ+ youth losing access to mental health care. The Human Rights Watch calls it a “crueler world for immigrants.” That’s putting it mildly.

This isn’t targeted enforcement. It’s a dragnet. Green card holders, long-term residents, and asylum seekers are swept up alongside undocumented workers. Viral videos show ICE raids at schools, hospitals, and churches. Lawsuits are piling up. And the chilling effect is real: immigrant communities are retreating from public life, afraid to report crimes or seek help. That’s not safety. That’s silence. Legal scholars warn that the administration’s tactics—raids at schools, churches, and hospitals—may violate Fourth Amendment protections and due process norms.

Even the administration’s security claims are shaky. Yes, border crossings are down—by about 60%, thanks to policies like “Remain in Mexico.” But deportation numbers haven’t met the promised scale. The Migration Policy Institute notes that monthly averages hover around 14,500, far below the millions touted. And the root causes of undocumented immigration—like visa overstays, which account for 60% of cases—remain untouched.

Crime reduction? Also murky. FBI data shows declines in some areas, but experts attribute this more to economic trends than immigration enforcement. In fact, fear in immigrant communities may be making things worse. When people won’t talk to the police, crimes go unreported. That’s not justice. That’s dysfunction.

Public opinion is catching up. In February, 59% of Americans supported mass deportations. By July, that number had cratered. Gallup reports a 25-point drop in favor of immigration cuts. The Pew Research Center finds that 75% of Democrats—and a growing number of independents—think the policy goes too far. Even Trump-friendly voices like Joe Rogan are balking, calling raids on “construction workers and gardeners” a betrayal of common sense.

On social media, the backlash is swift. Users on X (formerly Twitter) call the policy “ineffective,” “manipulative,” and “theater.” And they’re not wrong. This isn’t about solving immigration. It’s about staging a show—one where fear plays the villain and facts are the understudy.

The White House insists this is what voters wanted. But a narrow electoral win isn’t a blank check for policies that harm the economy and fray the social fabric. Alternatives exist: Targeted enforcement focused on violent offenders; visa reform to address overstays; and legal pathways to fill labor gaps. These aren’t radical ideas—they’re pragmatic ones. And they don’t require tearing families apart to work.

Trump’s deportation blitz is a mirage. It promises safety but delivers instability. It claims to protect jobs but undermines the very sectors that keep the country running. It speaks the language of law and order but acts with the recklessness of a demolition crew. Alternatives exist—and they work. Cities that focus on community policing and legal pathways report higher public safety and stronger economies. Reform doesn’t require cruelty. It requires courage.

Keep ReadingShow less